Tour de France 2024: New Frontiers in Cycling and Cancer Research
Elite cyclists' training insights could revolutionize cancer treatment, as the race begins with unpredictable contenders.
- Tour de France coach Iñigo San Millán explores the link between lactate metabolism in athletes and cancer cells.
- Tadej Pogacar, a favorite to win, benefits from advanced physiological training methods.
- Jonas Vingegaard and other top contenders face uncertainties due to recent injuries.
- San Millán's research aims to disrupt cancer's lactate production, potentially leading to new treatments.
- The 111th Tour de France starts in Florence, marking a wide-open race with multiple strong competitors.